<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04712318</url>
  </required_header>
  <id_info>
    <org_study_id>EHospitalPristina</org_study_id>
    <nct_id>NCT04712318</nct_id>
  </id_info>
  <brief_title>Treatment of Residual Refraction Errors 6 Months After Trifocal IOL Implantation With Relex-Smile</brief_title>
  <official_title>Succesful Treatment of Residual Refraction Errors (Myopic and Hyperopic) 6 Months After Trifocal IOL Implantation With Relex-Smile</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eye Hospital Pristina Kosovo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eye Hospital Pristina Kosovo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Successful treatment of residual refraction 6 months after IOL Implantation with Relex-Smile.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Residual refractive errors(myopia 50% and hyperopia 30%) are the main problems at patients&#xD;
      after IOL Implantation.&#xD;
&#xD;
      The residual refraction (myopic and hyperopic) after IOL Implantation is difficult to treat&#xD;
      surgically. In addition, there are not many suitable options to offer such patients&#xD;
      presenting with this condition.&#xD;
&#xD;
      Two current common surgeries to treat residual hyperopic refraction are refractive lens&#xD;
      exchange (RLE) and excimer laser ablation (LASIK or PRK).&#xD;
&#xD;
      Laser procedures: Photorefractive keratectomy (PRK); Laser assisted in situ keratomileusis&#xD;
      (LASIK); Risks of LASIK include abnormalities of the corneal flap, epithelial ingrowth,&#xD;
      corneal ectasia, refractive surprises, irregular astigmatism, decentration, visual&#xD;
      aberrations, a loss of BCVA, infectious keratitis, symptoms, and diffuse lamellar keratitis.&#xD;
&#xD;
      Refractive lens exchange (RLE); The risks of RLE are similar to those of cataract surgery and&#xD;
      include endophthalmitis, a loss of accommodation, vitreous loss with posterior capsular&#xD;
      rupture, and retinal detachment.&#xD;
&#xD;
      The aim of our study is to investigate the effect of Relex-Smile to treat the residual&#xD;
      refraction errors (myopia and hypermetropia) 6 months after IOL Implantation.&#xD;
&#xD;
      Before SMILE, Yag-Laser capsulotomy should be performed on all patients, regardless of&#xD;
      posterior capsule ossification, in pseudophakic patients with residual refraction. When the&#xD;
      YAG Laser is applied after the SMILE ,there will be a diopter change. In pseudophakic&#xD;
      patients with hyperopic astigmatism and residual refraction ,corneal topography-guided&#xD;
      intrastromal fresh lenticular implantation should be performed and the lenticule was placed&#xD;
      according to the low K value.&#xD;
&#xD;
      At myopic residual refraction(-0.75D till -5.50D) after IOL Implantation The method used at&#xD;
      the EYE Hospital Pristina by ReLex-SMILE is safe and effective method, since there is no flap&#xD;
      and this prevents invasive damage to the anterior surface of the cornea contrary to the LASIK&#xD;
      where flap is present posing risk for epithelial ingrowth.&#xD;
&#xD;
      At hyperopic residual refraction this study is to investigate the effect of fresh myopic&#xD;
      corneal lenticule implantation as allogenic implant(-1.50D) that will be taken from myopic&#xD;
      patients to implant on Pseudophakic patients with residual hypermetropia refraction (+1.0D)&#xD;
      using VisuMax Femtosecond laser - Smile module surgery&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Actual">June 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Myopic group 100 eyes hyperopic group 30 eyes</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase of visual acuity</measure>
    <time_frame>6 months</time_frame>
    <description>Increase of visual acuity by reducing residual refractive errors (myopia, hyperopia) using ReLex Smile after Trifocal IOL implantation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Pseudophakia</condition>
  <condition>Myopia</condition>
  <condition>Hyperopia</condition>
  <arm_group>
    <arm_group_label>ReLex Smile surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The aim of this study is to investigate the effect of Relex Smile surgery to correct the residual refractive errors (myopic and hyperopic) 6 months after Trifocal IOL Implantation.&#xD;
At myopic residual refraction (min -0.75 D) (100eyes) 6 months after Trifocal IOL Implantation we used Relex-Smile surgery for treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ReLex Smile surgery-fresh corneal lenticule implantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>At hyperopic residual refraction 30 eyes 6 months after Trifocal IOL Implantation we used fresh corneal myopic lenticule implantation as allogenic implant that will be taken from myopic patients to implant on pseudophakic patients with residual hypermetropic refraction using VisuMax Femtosecond Laser-Smile module surgery with primary objective to assess(increase) visual acuity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Relex Smile</intervention_name>
    <description>Procedure/Surgery: Relex Smile The residual myopic refraction on Pseudophakic patients after 6 months using Relex-Smile surgery by VisuMax femtosecond laser. The residual refractive power was min -0.75D.The optical zone (lenticule diameter) and cap diameter were 6.5 and 7.5 mm respectively. After dissection of both anterior and posterior planes, the lenticule was extracted through 120 degree superior 3.5 mm incision and marked with a sterile marker(ViscotMedster).</description>
    <arm_group_label>ReLex Smile surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Relex smile with fresh corneal lenticule implantation</intervention_name>
    <description>VisuMax femtosecond laser performed flap-cut procedure with an energy cut index of 30 nJ (150nJ), spot and track spacing surface cut of 4.5 μm, side cut 2.0 μm were used to create an intrastromal pocket into the patient's cornea to receive the donor lenticule.&#xD;
The stromal pocket diameter was set 7.6 to 8.0 mm (1 mm larger than the optical zone of the donor lenticule) and cap thickness was set to 130 μm from corneal surface and a 4 mm superior incision. Hinge position flap was set at 90°, angle 50° and width 4 mm, side cut angle 90°. The pocket was dissected using a blunt spatula washed with normal saline. The lenticule was held with lenticule forceps and gently inserted into the pocket through the 4 mm superior incision.&#xD;
In pseudophakic patients with hyperopic astigmatism residual refraction, corneal topography-guided intrastromal fresh lenticular implantation should be performed according to the low K values.</description>
    <arm_group_label>ReLex Smile surgery-fresh corneal lenticule implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  residual hypermetropic, myopic refraction on pseudophakic patients&#xD;
&#xD;
          -  low visual acuity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  active anterior segment pathologic features,&#xD;
&#xD;
          -  previous corneal or anterior segment surgery,&#xD;
&#xD;
          -  glaucoma,&#xD;
&#xD;
          -  retinal detachment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eye Hospital Pristina</name>
      <address>
        <city>Pristina</city>
        <zip>10000</zip>
        <country>Kosovo</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Kosovo</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 13, 2021</study_first_submitted>
  <study_first_submitted_qc>January 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 15, 2021</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eye Hospital Pristina Kosovo</investigator_affiliation>
    <investigator_full_name>Dr. Faruk Semiz</investigator_full_name>
    <investigator_title>Head of Ophthalmology Department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperopia</mesh_term>
    <mesh_term>Refractive Errors</mesh_term>
    <mesh_term>Pseudophakia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

